Pliant Therapeutics, Inc. (PLRX) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 174.93M | 196.45M | 245.59M | 267.44M | 311.19M | 362.26M | 410.03M | 447.55M | 489.9M | 505.5M | 534.34M | 565.7M |
| Cash & Short-Term Investments | 170.89M | 190.94M | 241.8M | 262.87M | 305.64M | 355.72M | 404.51M | 436.61M | 482.39M | 494.25M | 523.61M | 555.16M |
| Cash Only | 22.19M | 45.45M | 93.73M | 86.82M | 91.94M | 71.19M | 79.62M | 80.39M | 114.3M | 63.23M | 57.68M | 54.95M |
| Short-Term Investments | 148.7M | 145.5M | 148.06M | 176.05M | 213.71M | 284.54M | 324.9M | 356.22M | 368.09M | 431.01M | 465.93M | 500.21M |
| Accounts Receivable | 914K | 823K | 908K | 1.53M | 1.68M | 2.3M | 2.22M | 2.8M | 2.31M | 3M | 2.12M | 4.02M |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | 1.61K |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 3.12M | 1.13M | -908K | 75K | 57K | 163K | 685K | 741K | 611K | 1.27M | 668K | 229K |
| Total Non-Current Assets | 27.67M | 28.78M | 31.01M | 32.38M | 33.58M | 34.69M | 35.63M | 36.18M | 31.71M | 6.65M | 6.13M | 9.19M |
| Property, Plant & Equipment | 24.04M | 26.91M | 29.14M | 30.51M | 31.67M | 32.77M | 33.73M | 34.26M | 29.83M | 4.78M | 5.74M | 8.52M |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | 0.03x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 3.63M | 1.87M | 1.87M | 1.87M | 1.91M | 1.92M | 1.91M | 1.92M | 1.87M | 1.87M | 392K | 672K |
| Total Assets | 202.6M | 225.23M | 276.6M | 299.82M | 344.77M | 396.95M | 445.67M | 483.73M | 521.61M | 512.15M | 540.46M | 574.89M |
| Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | 0.00x |
| Asset Growth % | -41.24% | -43.26% | -37.94% | -38.02% | -33.9% | -22.49% | -17.54% | -15.86% | -12.76% | 46.07% | 43.29% | 211.39% |
| Total Current Liabilities | 10.36M | 16.36M | 17.62M | 20.59M | 28.2M | 33.22M | 39.95M | 30.92M | 30.39M | 28.52M | 27.39M | 29.52M |
| Accounts Payable | 362K | 480K | 485K | 1.38M | 5.62M | 5.96M | 6.89M | 3.25M | 7.33M | 4.53M | 3.36M | 2.31M |
| Days Payables Outstanding | 143.52 | - | - | 713.14 | - | - | - | 773.5 | 1.05K | - | - | 153.69 |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 8.28M | 8.3M | 0 | 6.23M | 5.39M | 11.15M | 8.42M | 6.61M | 4.54M | 9.04M | 6.68M | 5.75M |
| Current Ratio | 16.89x | 12.00x | 13.93x | 12.99x | 11.03x | 10.91x | 10.26x | 14.47x | 16.12x | 17.72x | 19.50x | 19.16x |
| Quick Ratio | 16.89x | 12.00x | 13.93x | 12.99x | 11.03x | 10.91x | 10.26x | 14.47x | 16.12x | 17.72x | 19.50x | 19.16x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 27.07M | 27.66M | 58.67M | 59.15M | 59.4M | 59.65M | 59.89M | 60.13M | 53.88M | 10.05M | 10.02M | 12.31M |
| Long-Term Debt | 0 | 0 | 30.44M | 30.36M | 30.28M | 30.21M | 30.14M | 30.07M | 30M | 10.05M | 10.02M | 9.99M |
| Capital Lease Obligations | 27.07M | 27.66M | 28.23M | 28.79M | 29.12M | 29.44M | 29.75M | 30.06M | 23.88M | 0 | 0 | 2.32M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 37.43M | 44.02M | 76.29M | 79.74M | 87.61M | 92.87M | 99.84M | 91.05M | 84.27M | 38.58M | 37.42M | 41.83M |
| Total Debt | 28.78M | 29.11M | 59.86M | 60.38M | 60.17M | 60.19M | 60.21M | 60.23M | 54.66M | 11.37M | 12.08M | 14.54M |
| Net Debt | 6.59M | -16.34M | -33.88M | -26.44M | -31.76M | -11M | -19.4M | -20.16M | -59.64M | -51.86M | -45.6M | -40.41M |
| Debt / Equity | 0.17x | 0.16x | 0.30x | 0.27x | 0.23x | 0.20x | 0.17x | 0.15x | 0.12x | 0.02x | 0.02x | 0.03x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | -172.36x | -8.45x | -52.52x | -69.30x | -58.63x | -64.86x | -63.35x | -104.52x | -127.07x | -129.87x | -128.13x |
| Total Equity | 165.17M | 181.21M | 200.31M | 220.08M | 257.16M | 304.08M | 345.82M | 392.68M | 437.33M | 473.58M | 503.05M | 533.07M |
| Equity Growth % | -35.77% | -40.41% | -42.08% | -43.95% | -41.2% | -35.79% | -31.25% | -26.34% | -22.17% | 51.14% | 49.28% | 260.7% |
| Book Value per Share | 2.67 | 2.95 | 3.26 | 3.59 | 4.20 | 5.02 | 5.69 | 6.50 | 7.27 | 7.91 | 8.43 | 9.01 |
| Total Shareholders' Equity | 165.17M | 181.21M | 200.31M | 220.08M | 257.16M | 304.08M | 345.82M | 392.68M | 437.33M | 473.58M | 503.05M | 533.07M |
| Common Stock | 6K | 6K | 6K | 6K | 6K | 6K | 6K | 6K | 6K | 6K | 6K | 6K |
| Retained Earnings | -879.44M | -859.4M | -835.82M | -809.52M | -766.22M | -710.05M | -660.32M | -602.56M | -546.7M | -499.75M | -458.64M | -417.15M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -341K | -15K | 34K | -1K | 159K | 321K | 848K | -617K | -489K | 345K | -1.91M | -2.24M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |